195 related articles for article (PubMed ID: 24304617)
1. Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC).
Hashiguchi M; Ueno S; Sakoda M; Iino S; Hiwatashi K; Minami K; Ando K; Mataki Y; Maemura K; Shinchi H; Ishigami S; Natsugoe S
BMC Cancer; 2013 Dec; 13():572. PubMed ID: 24304617
[TBL] [Abstract][Full Text] [Related]
2. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
[TBL] [Abstract][Full Text] [Related]
3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
[TBL] [Abstract][Full Text] [Related]
5. Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.
Zhan DQ; Wei S; Liu C; Liang BY; Ji GB; Chen XP; Xiong M; Huang ZY
J Gastroenterol Hepatol; 2012 Jan; 27(1):173-80. PubMed ID: 21777276
[TBL] [Abstract][Full Text] [Related]
6. Expression of HnRNP A1, ZEB1, and E-cadherin in Hepatocellular carcinoma and their impact on patients' prognosis and survival.
Abouhashem NS; Elwan A; El Hefnawy AS; Atwa HA
Indian J Pathol Microbiol; 2022; 65(3):589-597. PubMed ID: 35900486
[TBL] [Abstract][Full Text] [Related]
7. BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma.
Xiao S; Liu L; Fang M; Zhou X; Peng X; Long J; Lu X
Dig Dis Sci; 2015 Apr; 60(4):910-8. PubMed ID: 25362514
[TBL] [Abstract][Full Text] [Related]
8. Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
Liu J; Ni W; Qu L; Cui X; Lin Z; Liu Q; Zhou H; Ni R
Dig Dis Sci; 2016 Sep; 61(9):2554-67. PubMed ID: 27221498
[TBL] [Abstract][Full Text] [Related]
9. Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells.
Singh AB; Sharma A; Smith JJ; Krishnan M; Chen X; Eschrich S; Washington MK; Yeatman TJ; Beauchamp RD; Dhawan P
Gastroenterology; 2011 Dec; 141(6):2140-53. PubMed ID: 21878201
[TBL] [Abstract][Full Text] [Related]
10. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
11. Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC.
Zhai X; Zhu H; Wang W; Zhang S; Zhang Y; Mao G
Med Oncol; 2014 Jun; 31(6):970. PubMed ID: 24781336
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of E-cadherin, CD34 in the patients with hepatocellular carcinoma].
Wu LQ; Lu Y; Lu HJ; Zhang B; Yang JY; Ma X
Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):774-7. PubMed ID: 16836930
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CSN6 promotes the epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma.
Xu M; Zhen L; Lin L; Wu K; Wang Y; Cai X
Clin Res Hepatol Gastroenterol; 2020 Jun; 44(3):340-348. PubMed ID: 31422034
[TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
[TBL] [Abstract][Full Text] [Related]
15. The expression of chitinase 3-like 1: a novel prognostic predictor for hepatocellular carcinoma.
Pan JJ; Ge YS; Xu GL; Jia WD; Liu WF; Li JS; Liu WB
J Cancer Res Clin Oncol; 2013 Jun; 139(6):1043-54. PubMed ID: 23525579
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of ZEB-1 and E-cadherin proteins in patients with oral cavity squamous cell carcinoma.
Yao X; Sun S; Zhou X; Zhang Q; Guo W; Zhang L
Onco Targets Ther; 2017; 10():781-790. PubMed ID: 28243114
[TBL] [Abstract][Full Text] [Related]
17. The microRNA-200 family--a potential diagnostic marker in hepatocellular carcinoma?
Dhayat SA; Mardin WA; Köhler G; Bahde R; Vowinkel T; Wolters H; Senninger N; Haier J; Mees ST
J Surg Oncol; 2014 Sep; 110(4):430-8. PubMed ID: 24895326
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition and mesenchymal-epithelial transition via regulation of ZEB-1 and ZEB-2 expression in pancreatic cancer.
Kurahara H; Takao S; Maemura K; Mataki Y; Kuwahata T; Maeda K; Ding Q; Sakoda M; Iino S; Ishigami S; Ueno S; Shinchi H; Natsugoe S
J Surg Oncol; 2012 Jun; 105(7):655-61. PubMed ID: 22213144
[TBL] [Abstract][Full Text] [Related]
19. Epithelial-to-mesenchymal transition predicts prognosis in clinical gastric cancer.
Murai T; Yamada S; Fuchs BC; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Tanabe KK; Kodera Y
J Surg Oncol; 2014 Jun; 109(7):684-9. PubMed ID: 24453058
[TBL] [Abstract][Full Text] [Related]
20. Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma.
Guo C; Liu QG; Yang W; Zhang ZL; Yao YM
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):490-6. PubMed ID: 18842495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
